Chelatexx (Reformulated Orlistat) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Chelatexx (Reformulated Orlistat) General Information
Description
Manufacturer of C-103, a reformulated version of orlistat for weight management. Orlistat is marketed in prescription strength by Roche Laboratories (Xenical(R) 120mg capsules) and in over-the-counter strength by GlaxoSmithKline Consumer Healthcare (alli(R) 60mg capsules). Orlistat is an FDA-approved weight management drug for a pediatric population (adolescents 12 years and older).
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Office
- 110 Stanbery Ridge
- Fort Thomas, KY 41075
- United States
Chelatexx (Reformulated Orlistat) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Chelatexx (Reformulated Orlistat) Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Gary Thompson | President & Chief Executive Officer |